Jha Ashish Kumar, Mithun Sneha, Puranik Ameya, Purandare Nilendu C, Shah Sneha, Agrawal Archi, Kulkarni Suyash S, Shetty Nitin, Rangarajan Venkatesh
Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Department of Raiodiagnosis, Tata Memorial Hospital, Mumbai, Maharashtra, India.
World J Nucl Med. 2019 Dec 18;18(4):366-372. doi: 10.4103/wjnm.WJNM_115_18. eCollection 2019 Oct-Dec.
Trans-arterial radioembolization (TARE) is an established treatment for inoperable hepatocellular carcinoma and liver metastases from Carcinoma of gastrointestinal tract. Radiation-induced toxicity to the lung parenchyma is the dose-limiting factor in TARE. Pretreatment hepatopulmonary shunt (HPS) is estimated by gamma camera method by transarterial administration of 370MBq Tc macro aggregated albumin. We have developed HPS software on XELERIS-1.123 workstation, GE medical systems, Milwaukee, USA, for accurate calculation of HPS. This software has also been tested on a higher version of XELERIS workstation, and it has been found to work well in all versions.
经动脉放射性栓塞术(TARE)是一种用于无法手术切除的肝细胞癌和胃肠道癌肝转移的既定治疗方法。辐射对肺实质的毒性是TARE中的剂量限制因素。通过经动脉注射370MBq锝标记的大聚合白蛋白,利用γ相机法估算治疗前的肝肺分流(HPS)。我们在美国密尔沃基的通用电气医疗系统公司的XELERIS-1.123工作站上开发了HPS软件,用于准确计算HPS。该软件也已在更高版本的XELERIS工作站上进行了测试,并且发现在所有版本中都能正常运行。